|

Tislelizumab in Combination with Bacillus Calmette-Guérin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Fujian Medical University Union Hospital1

Indications

  • Neoplasm Recurrence, Local1
  • Multicenter Study1
  • BCG Vaccine1
  • Immunotherapy, Active1
  • Treatment Outcome1

Other1 trial

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.